Evidence map›Paper›PMID 36973281›Full record

ArticleNature communications2023

Helicobacter pylori initiates successful gastric colonization by utilizing L-lactate to promote complement resistance.

Shuai Hu, Karen M Ottemann

Open access · goldFull text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Characterization ofJournal of bacteriology · 2026
    Article
  2. Review
  3. Review
  4. Specificities of chemosensory receptors in the human gut microbiota.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. Frontiers in microbiology · 2025
    Review
  8. Metabolic reprogramming inFrontiers in cellular and infection microbiology · 2025
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shuai HuDepartment of Microbiology and Environmental Toxicology, University of California, Santa Cruz, CA, 95064, USA.ORCID 0000-0003-1825-0414
Karen M OttemannDepartment of Microbiology and Environmental Toxicology, University of California, Santa Cruz, CA, 95064, USA. ottemann@ucsc.edu.ORCID 0000-0001-6265-7401
University of California, Santa Cruz · US

Funding

The function of chemotactic signal transduction during colonization and diseaseR01AI116946 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI OTTEMANN, KAREN M · 2016 to 2025
$5.1M
H. pylori lactate finding, utilization, and creation during stomach colonizationR21AI144740 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI OTTEMANN, KAREN M · 2019 to 2020
$366k
NIAID NIH HHS R01 AI116946NIAID NIH HHS R21 AI144740
6 · The paper itself

Abstract

The complement system has long been appreciated for its role in bloodborne infections, but its activities in other places, including the gastrointestinal tract, remain elusive. Here, we report that complement restricts gastric infection by the pathogen Helicobacter pylori. This bacterium colonized complement-deficient mice to higher levels than wild-type counterparts, particularly in the gastric corpus region. H. pylori uses uptake of the host molecule L-lactate to create a complement-resistant state that relies on blocking the deposition of the active complement C4b component on H. pylori's surface. H. pylori mutants unable to achieve this complement-resistant state have a significant mouse colonization defect that is largely corrected by mutational removal of complement. This work highlights a previously unknown role for complement in the stomach, and has revealed an unrecognized mechanism for microbial-derived complement resistance.

Indexed as

Helicobacter InfectionsHelicobacter pyloriAnimalsGastric MucosaLactic AcidMiceStomachLactic Acid

Identifiers

PMID36973281
PMCPMC10042806
OpenAlexW4360989968

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read91
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.